Delaware
|
001-37568
|
26-4231384
|
(State or Other Jurisdiction
of Incorporation or Organization)
|
(Commission
File Number)
|
(I.R.S. Employer
Identification No.)
|
300 Connell Drive, Suite 4000
Berkeley Heights, NJ
|
07922
|
(Address of Principal Executive Offices)
|
(Zip Code)
|
☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
☐
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
☐
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
☐
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item 2.02
|
Results of Operations and Financial Condition
|
Item 9.01. |
Financial Statements and Exhibits
|
Exhibit
Number
|
Description
|
99.1
|
Press release dated November 1, 2018 announcing financial results for the three months ended September 30, 2018.
|
Dated: November 1, 2018
|
Edge Therapeutics, Inc.
|
||
By: /s/ Andrew Saik
|
|||
|
Name: Andrew Saik |
||
|
Title: Chief Financial Officer |
Exhibit
Number |
Description
|
Press release dated November 1, 2018 announcing financial results for the three months ended September 30, 2018.
|